Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria

Molecular Genetics and Metabolism

Volumn 103, Issue 4, 2011, Pages 330-337

  Keating, Amy K ^a   Freehauf, Cynthia ^a   Jiang, Hua ^a   Brodsky, Gary L ^a   Stabler, Sally P ^b   Allen, Robert H ^b   Graham, Douglas K ^a   Thomas, Janet A ^a   Van Hove, Johan L K ^a   Maclean, Kenneth N ^a  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Cystathionine beta synthase; Cytokine; Homocysteine; Homocystinuria; Interleukin 1; Tumor necrosis factor alpha

Indexed keywords

BETAINE; C REACTIVE PROTEIN; CHEMOKINE; CYSTATHIONINE BETA SYNTHASE; CYSTEINE; DIMETHYLGLYCINE; FRACTALKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; THIOL; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AMINO ACID ANALYSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BLOOD LEVEL; CHILD; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HOMOCYSTINURIA; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN RESTRICTION; SCHOOL CHILD; THROMBOSIS;

ADOLESCENT; ADULT; ANIMALS; BETAINE; CHEMOKINE CCL4; CHEMOKINES; CHILD; CHILD, PRESCHOOL; CYSTATHIONINE BETA-SYNTHASE; FEMALE; HOMOCYSTINURIA; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICE; MICE, TRANSGENIC; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 79960848132     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.04.012     Document Type: Article

References (54)

1. Mudd S.H., Levy H.L., Kraus J.P. Disorders of transsulfuration. The Metabolic and Molecular Bases of Inherited Disease 2001, 2007-2056. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, B. Childs, K. Kinzler, B. Vogelstein (Eds.).
2. Selhub J. Mild hyperhomocysteinemia and arterial occlusive disease. Haematologica 1997, 82:129-132.
3. D'Angelo A., Selhub J. Homocysteine and thrombotic disease. Blood 1997, 90:1-11.
4. Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M., McQueen M.J., Probstfield J., Fodor G., Held C., Genest J. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 2006, 354:1567-1577.
5. Bonaa K.H., Njolstad I., Ueland P.M., Schirmer H., Tverdal A., Steigen T., Wang H., Nordrehaug J.E., Arnesen E., Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 2006, 354:1578-1588.
6. Mudd S.H., Skovby F., Levy H.L., Pettigrew K.D., Wilcken B., Pyeritz R.E., Andria G., Boers G.H.J., Bromberg I.L., Cerone R., Fowler B., Grobe H., Schmidt H., Schweitzer L. The natural history of homocystinuria due to cystathionine b-synthase deficiency. Am. J. Hum. Genet. 1985, 37:1-31.
7. Hanada T., Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 2002, 13:413-421.
8. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
9. Maclean K.N., Sikora J., Kozich V., Jiang H., Greiner L.S., Kraus E., Krijt J., Overdier K.H., Collard R., Brodsky G.L., Meltesen L., Crnic L.S., Allen R.H., Stabler S.P., Elleder M., Rozen R., Patterson D., Kraus J.P. A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment. Mol. Genet. Metab. 2010, 101:153-162.
10. Allen R.H., Stabler S.P., Lindenbaum J. Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism 1993, 42:1448-1460.
11. Stabler S.P., Lindenbaum J., Savage D.G., Allen R.H. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993, 81:3404-3413.
12. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 2000, 342:836-843.
13. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997, 349:462-466.
14. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell 1994, 76:253-262.
15. Abdelmalek M.F., Angulo P., Jorgensen R.A., Sylvestre P.B., Lindor K.D. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am. J. Gastroenterol. 2001, 96:2711-2717.
16. Maclean K.N., Sikora J., Kozich V., Jiang H., Greiner L.S., Kraus E., Krijt J., Crnic L.S., Allen R.H., Stabler S.P., Elleder M., Kraus J.P. Cystathionine beta-synthase null homocystinuric mice fail to exhibit altered hemostasis or lowering of plasma homocysteine in response to betaine treatment. Mol. Genet. Metab. 2010, 101:163-171.
17. Kofler S., Nickel T., Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin. Sci. (Lond.) 2005, 108:205-213.
18. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 2009, 361:888-898.
19. Aggarwal S., Gurney A.L. IL-17: prototype member of an emerging cytokine family. J. Leukoc. Biol. 2002, 71:1-8.
20. Demetri G.D., Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood 1991, 78:2791-2808.
21. Renauld J.C., Houssiau F., Louahed J., Vink A., Van Snick J., Uyttenhove C. Interleukin-9. Adv. Immunol. 1993, 54:79-97.
22. Derynck R. The physiology of transforming growth factor-alpha. Adv. Cancer Res. 1992, 58:27-52.
23. Poddar R., Sivasubramanian N., DiBello P.M., Robinson K., Jacobsen D.W. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 2001, 103:2717-2723.
24. Dalal S., Parkin S.M., Homer-Vanniasinkam S., Nicolaou A. Effect of homocysteine on cytokine production by human endothelial cells and monocytes. Ann. Clin. Biochem. 2003, 40:534-541.
25. Su S.J., Huang L.W., Pai L.S., Liu H.W., Chang K.L. Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition 2005, 21:994-1002.
26. Pober J.S. Immunobiology of human vascular endothelium. Immunol. Res. 1999, 19:225-232.
27. Eberhardt R.T., Forgione M.A., Cap A., Leopold J.A., Rudd M.A., Trolliet M., Heydrick S., Stark R., Klings E.S., Moldovan N.I., Yaghoubi M., Goldschmidt-Clermont P.J., Farber H.W., Cohen R., Loscalzo J. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J. Clin. Invest. 2000, 106:483-491.
28. Yoshizumi M., Perrella M.A., Burnett J.C., Lee M.E. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 1993, 73:205-209.
29. Aoki N., Siegfried M., Lefer A.M. Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am. J. Physiol. 1989, 256:H1509-H1512.
30. Iversen P.O., Nicolaysen A., Kvernebo K., Benestad H.B., Nicolaysen G. Human cytokines modulate arterial vascular tone via endothelial receptors. Pflugers Arch. 1999, 439:93-100.
31. Katz S.D., Rao R., Berman J.W., Schwarz M., Demopoulos L., Bijou R., LeJemtel T.H. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 1994, 90:12-16.
32. Vanderheyden M., Kersschot E., Paulus W.J. Pro-inflammatory cytokines and endothelium-dependent vasodilation in the forearm. Serial assessment in patients with congestive heart failure. Eur. Heart J. 1998, 19:747-752.
33. Shebuski R.J., Kilgore K.S. Role of inflammatory mediators in thrombogenesis. J. Pharmacol. Exp. Ther. 2002, 300:729-735.
34. Tousoulis D., Davies G., Stefanadis C., Toutouzas P., Ambrose J.A. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 2003, 89:993-997.
35. Sohn R.H., Deming C.B., Johns D.C., Champion H.C., Bian C., Gardner K., Rade J.J. Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood 2005, 105:3910-3917.
36. Esmon C.T. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. Baillieres Best Pract. Res. Clin. Haematol. 1999, 12:343-359.
37. Gear A.R., Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 2003, 10:335-350.
38. Barksby H.E., Lea S.R., Preshaw P.M., Taylor J.J. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin. Exp. Immunol. 2007, 149:217-225.
39. Xiao N., Yin M., Zhang L., Qu X., Du H., Sun X., Mao L., Ren G., Zhang C., Geng Y., An L., Pan J. Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice. Mol. Genet. Metab. 2009, 96:239-244.
40. Truman L.A., Ford C.A., Pasikowska M., Pound J.D., Wilkinson S.J., Dumitriu I.E., Melville L., Melrose L.A., Ogden C.A., Nibbs R., Graham G., Combadiere C., Gregory C.D. CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 2008, 112:5026-5036.
41. Garcia G.E., Xia Y., Chen S., Wang Y., Ye R.D., Harrison J.K., Bacon K.B., Zerwes H.G., Feng L. NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS. J. Leukoc. Biol. 2000, 67:577-584.
42. Lukacs N.W., Strieter R.M., Elner V.M., Evanoff H.L., Burdick M., Kunkel S.L. Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1 alpha during monocyte-endothelial cell interactions. Blood 1994, 83:1174-1178.
43. Mundy G.R. Osteoporosis and inflammation. Nutr. Rev. 2007, 65:S147-S151.
44. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 1991, 259:988-996.
45. Gemma C., Ghezzi P., De Simoni M.G. Activation of the hypothalamic serotoninergic system by central interleukin-1. Eur. J. Pharmacol. 1991, 209:139-140.
46. Brett F.M., Mizisin A.P., Powell H.C., Campbell I.L. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Exp. Neurol. 1995, 54:766-775.
47. Steffensen S.C., Campbell I.L., Henriksen S.J. Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res. 1994, 652:149-153.
48. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:10061-10065.
49. Fallon J., Reid S., Kinyamu R., Opole I., Opole R., Baratta J., Korc M., Endo T.L., Duong A., Nguyen G., Karkehabadhi M., Twardzik D., Patel S., Loughlin S. In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:14686-14691.
50. Fontaine R.H., Cases O., Lelievre V., Mesples B., Renauld J.C., Loron G., Degos V., Dournaud P., Baud O., Gressens P. IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ. 2008, 15:1542-1552.
51. Boehme S.A., Lio F.M., Maciejewski-Lenoir D., Bacon K.B., Conlon P.J. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J. Immunol. 2000, 165:397-403.
52. Janssen Y.M., Van Houten B., Borm P.J., Mossman B.T. Cell and tissue responses to oxidative damage. Lab. Invest. 1993, 69:261-274.
53. Go E.K., Jung K.J., Kim J.Y., Yu B.P., Chung H.Y. Betaine suppresses proinflammatory signaling during aging: the involvement of nuclear factor-kappaB via nuclear factor-inducing kinase/IkappaB kinase and mitogen-activated protein kinases. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60:1252-1264.
54. Maclean K.N., Gaustadnes M., Oliveriusova J., Janosik M., Kraus E., Kozich V., Kery V., Skovby F., Rudiger N., Ingerslev J., Stabler S.P., Allen R.H., Kraus J.P. High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations. Hum. Mutat. 2002, 19:641-655.